Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$213K Hold
1,786
0.05% 112
2025
Q4
$243K Hold
1,786
0.06% 105
2025
Q3
$263K Hold
1,786
0.06% 107
2025
Q2
$231K Hold
1,786
0.06% 108
2025
Q1
$213K Hold
1,786
0.06% 97
2024
Q4
$207K Hold
1,786
0.07% 105
2024
Q3
$241K Hold
1,786
0.08% 135
2024
Q2
$242K Hold
1,786
0.09% 135
2024
Q1
$231K Hold
1,786
0.09% 141
2023
Q4
$204K Buy
+1,786
New +$178K 0.09% 132
2023
Q3
Sell
-1,786
Closed -$201K 153
2023
Q2
$201K Buy
+1,786
New +$189K 0.09% 141
2022
Q1
Sell
-1,786
Closed -$214K 151
2021
Q4
$214K Hold
1,786
0.1% 130
2021
Q3
$221K Hold
1,786
0.12% 129
2021
Q2
$214K Buy
+1,786
New +$204K 0.11% 140
2019
Q4
Sell
-1,786
Closed -$142K 347
2019
Q3
$142K Buy
+1,786
New +$140K 0.11% 112

Other funds holding XYL

Weil Company's XYL Position: Q1 2026 in Review

Weil Company held its Xylem (XYL) position steady in Q1 2026 at 1,786 shares worth $213K. The position accounts for 0.05% of the portfolio, ranked #112.

Weil Company first reported a position in XYL in Q3 2019 and has held it in 15 quarters since. The position peaked at $263K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Weil Company held 1,786 shares of Xylem worth $213K as of Q1 2026.
  • Weil Company left its Xylem share count unchanged in Q1 2026.
  • Xylem made up 0.05% of Weil Company's portfolio in Q1 2026, its #112 holding.
  • Weil Company first reported a position in Xylem in Q3 2019 and has held it in 15 quarters since.
  • Weil Company's Xylem position peaked at $263K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Weil Company's 13F filing for Q1 2026, filed 15 Apr 2026.